2 assets in Urinary Tract Infection

Therapeutic assets addressing Urinary Tract Infection, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Gentamicin Urinary Tract Infection	Medstar Health Research Institute	Early P1	C (39)
Lactobacillus Rhamnosus Gg Urinary Tract Infection	Medstar Health Research Institute	Early P1	C (39)